DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression
Authors:
- Susanne KleinSKSusanne Klein
- Sabine Blass-KampmannSBSabine Blass-Kampmann
- Annette HintelmannAHAnnette Hintelmann
- Christina EilertCEChristina Eilert
- Stephan DreschersSDStephan Dreschers
- Holger KalthoffHKHolger Kalthoff
- Stephan A HahnSHStephan A Hahn
- Wolff SchmiegelWSWolff Schmiegel
- 20 May 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (20) , 3152-3158
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 30 references indexed in Scilit:
- Landscaping the Cancer TerrainScience, 1998
- TGF-β receptor signalingBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
- Cancer gets Mad: DPC4 and other TGFβ pathway genes in human cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Negative regulation of cell growth by TGFβBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996
- CANCER BIOLOGY: Type II TGFβ receptor expression in intestinal cell lines and in the intestinal tractCarcinogenesis, 1996
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor β inhibits proliferation and stimulates differentiationBiochemical and Biophysical Research Communications, 1987
- Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutationsNature, 1983